Quanterix Corp. Announces 2024 Annual Stockholder Meeting on June 3
Ticker: QTRX · Form: DEF 14A · Filed: Apr 15, 2024 · CIK: 1503274
| Field | Detail |
|---|---|
| Company | Quanterix Corp (QTRX) |
| Form Type | DEF 14A |
| Filed Date | Apr 15, 2024 |
| Risk Level | low |
| Pages | 16 |
| Reading Time | 19 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy statement, annual meeting, stockholders, board of directors, executive compensation
TL;DR
<b>Quanterix Corporation will convene its 2024 annual meeting of stockholders on June 3, 2024, to elect directors, vote on executive compensation, and ratify auditor appointments.</b>
AI Summary
Quanterix Corp (QTRX) filed a Proxy Statement (DEF 14A) with the SEC on April 15, 2024. Quanterix Corporation will hold its 2024 annual meeting of stockholders on June 3, 2024, at 10:00 a.m. ET. The meeting will take place at Quanterix's offices located at 900 Middlesex Turnpike, Building 1, Billerica, MA 01821. Two directors will be elected to the Board of Directors for three-year terms expiring in 2027. Stockholders will vote on an advisory basis for the compensation of named executive officers. The appointment of Ernst & Young LLP as the independent registered public accounting firm for fiscal year ending December 31, 2024, will be ratified.
Why It Matters
For investors and stakeholders tracking Quanterix Corp, this filing contains several important signals. This meeting is a critical governance event where shareholders have the opportunity to influence the company's direction by electing board members and providing feedback on executive pay. The ratification of the independent auditor is a standard but important procedural step that ensures financial oversight and transparency.
Risk Assessment
Risk Level: low — Quanterix Corp shows low risk based on this filing. The filing is a routine proxy statement with no immediate financial or operational news, indicating a low level of immediate risk.
Analyst Insight
Stockholders should review the proxy materials to make informed voting decisions on director nominees, executive compensation, and auditor ratification.
Key Numbers
- June 3, 2024 — Annual Meeting Date (2024 annual meeting of stockholders)
- 2027 — Director Term Expiration (three-year terms expiring in 2027)
- December 31, 2024 — Fiscal Year End (fiscal year ending December 31, 2024)
Key Players & Entities
- Quanterix Corp. (company) — Registrant
- Ernst & Young LLP (company) — independent registered public accounting firm
- June 3, 2024 (date) — Date of annual meeting
- 2027 (date) — Director term expiration
- December 31, 2024 (date) — Fiscal year end
- 900 Middlesex Turnpike, Building 1, Billerica, MA 01821 (location) — Meeting location
FAQ
When did Quanterix Corp file this DEF 14A?
Quanterix Corp filed this Proxy Statement (DEF 14A) with the SEC on April 15, 2024.
What is a DEF 14A filing?
A DEF 14A is a definitive proxy statement sent to shareholders before annual meetings, covering executive compensation, board nominations, and shareholder votes. This particular DEF 14A was filed by Quanterix Corp (QTRX).
Where can I read the original DEF 14A filing from Quanterix Corp?
You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by Quanterix Corp.
What are the key takeaways from Quanterix Corp's DEF 14A?
Quanterix Corp filed this DEF 14A on April 15, 2024. Key takeaways: Quanterix Corporation will hold its 2024 annual meeting of stockholders on June 3, 2024, at 10:00 a.m. ET.. The meeting will take place at Quanterix's offices located at 900 Middlesex Turnpike, Building 1, Billerica, MA 01821.. Two directors will be elected to the Board of Directors for three-year terms expiring in 2027..
Is Quanterix Corp a risky investment based on this filing?
Based on this DEF 14A, Quanterix Corp presents a relatively low-risk profile. The filing is a routine proxy statement with no immediate financial or operational news, indicating a low level of immediate risk.
What should investors do after reading Quanterix Corp's DEF 14A?
Stockholders should review the proxy materials to make informed voting decisions on director nominees, executive compensation, and auditor ratification. The overall sentiment from this filing is neutral.
How does Quanterix Corp compare to its industry peers?
Quanterix Corporation operates in the laboratory analytical instruments industry, providing solutions for life science research and diagnostics.
Are there regulatory concerns for Quanterix Corp?
The filing is made under Section 14(a) of the Securities Exchange Act of 1934, which governs the solicitation of proxies.
Risk Factors
- SEC Rules Compliance [low — regulatory]: The company must comply with SEC rules regarding proxy material delivery and disclosure.
- Meeting Logistics [low — operational]: Ensuring smooth execution of the annual meeting, including proxy voting and attendance.
Industry Context
Quanterix Corporation operates in the laboratory analytical instruments industry, providing solutions for life science research and diagnostics.
Regulatory Implications
The filing is made under Section 14(a) of the Securities Exchange Act of 1934, which governs the solicitation of proxies.
What Investors Should Do
- Review the proxy statement for details on director nominees and their qualifications.
- Evaluate the company's disclosed executive compensation practices.
- Confirm the ratification of Ernst & Young LLP as the independent auditor.
Key Dates
- 2024-06-03: Annual Meeting of Stockholders — Election of directors, advisory vote on executive compensation, ratification of auditor.
- 2024-04-15: Filing Date — Filing of the definitive proxy statement.
Year-Over-Year Comparison
This is the initial filing for the 2024 proxy season, providing details for the upcoming annual meeting.
Filing Stats: 4,862 words · 19 min read · ~16 pages · Grade level 11.5 · Accepted 2024-04-15 16:00:30
Filing Documents
- tm242735-2_def14a.htm (DEF 14A) — 957KB
- fc_compensation-4c.jpg (GRAPHIC) — 75KB
- lc_totalshare-bw.jpg (GRAPHIC) — 32KB
- lg_quanterixreg-4c.jpg (GRAPHIC) — 13KB
- pc_ceocfo-4c.jpg (GRAPHIC) — 20KB
- px_24quanterixproxy1pg1-4c.jpg (GRAPHIC) — 365KB
- px_24quanterixproxy1pg2-4c.jpg (GRAPHIC) — 238KB
- sg_lauriechurchill-bw.jpg (GRAPHIC) — 4KB
- sg_masoudtoloue-bw.jpg (GRAPHIC) — 4KB
- 0001104659-24-047245.txt ( ) — 3683KB
- qtrx-20231231.xsd (EX-101.SCH) — 8KB
- qtrx-20231231_def.xml (EX-101.DEF) — 7KB
- qtrx-20231231_lab.xml (EX-101.LAB) — 26KB
- qtrx-20231231_pre.xml (EX-101.PRE) — 10KB
- tm242735-2_def14a_htm.xml (XML) — 239KB
Security Ownership of Certain Beneficial Owners and Management
Security Ownership of Certain Beneficial Owners and Management 6 Management and Corporate Governance 8 Compensation Committee Report 17 Compensation Discussion and Analysis 18 Executive Officer and Director Compensation 28 Equity Compensation Plan Information 40 Report of Audit Committee 41 Additional Information Regarding our Independent Registered Public Accounting Firm 42 Delinquent Section 16(a) Reports 44 Certain Relationships and Related Person Transactions 45 Proposal No. 1: Election of Directors 47 Proposal No. 2: Advisory Vote on Approval of Executive Compensation 48 Proposal No. 3: Ratification of the Appointment of Independent Registered Public Accounting Firm 49 Corporate Code of Conduct and Ethics 50 Other Matters 50 Stockholder Proposals and Nominations for Director 50 TABLE OF CONTENTS QUANTERIX CORPORATION 900 Middlesex Turnpike Billerica, Massachusetts 01821 PROXY STATEMENT FOR 2024 ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON JUNE 3, 2024 This proxy statement, along with the accompanying Notice of 2024 Annual Meeting of Stockholders, contains information about the 2024 annual meeting of stockholders of Quanterix Corporation to be held at 10:00 a.m. ET, at our offices located at 900 Middlesex Turnpike, Building 1, Billerica, MA 01821. If the annual meeting is adjourned for any reason, then proxies submitted may be used at any adjournment of the 2024 annual meeting. In this proxy statement, we refer to Quanterix Corporation as "Quanterix," "the Company," "we" and "us." This proxy statement relates to the solicitation of proxies by our Board of Directors for use at the annual meeting. On or about April 15, 2024, we intend to begin sending the Important Notice Regarding the Availability of Proxy Materials to stockholders entitled to vote at the annual meeting. IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE STOCKHOLDER MEETING TO BE HELD ON JUNE
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT The following table sets forth certain information with respect to the beneficial ownership of our common stock as of March 1, 2024, for (a) the named executive officers in the Summary Compensation Table on page 28 of this proxy statement, (b) each of our directors and director nominees, (c) all of our current directors and executive officers as a group and (d) each stockholder known by us to own beneficially more than 5% of our common stock. Shares Beneficially Owned (1) Name and Address of Beneficial Owner Number Percent 5% Stockholders (2) BlackRock, Inc. (3) 50 Hudson Yards New York, NY 10001 3,190,625 8.4 % Millenium Management LLC et al. (4) 399 Park Avenue New York, NY 10022 2,209,566 5.8 % The Vanguard Group (5) 100 Vanguard Blvd. Malvern, PA 19355 2,055,033 5.4 % Directors, Director Nominees and Named Executive Officers Masoud Toloue, Ph.D. (6) 299,538 * Vandana Sriram — — Brian J. Blaser (7) 16,098 * William Donnelly 20,888 * Karen A. Flynn (8) 39,438 * Sarah E. Hlavinka (9) 87,768 * Martin D. Madaus, Ph.D. (10) 328,885 * Paul M. Meister (11) 337,496 * Laurie J. Olson (12) 43,217 * David R. Walt, Ph.D. (13) 1,487,121 3.9 % Michael A. Doyle (14) 97,061 * All directors and current executive officers as a group (10 persons) (15) 2,660,449 6.9 % * Represents beneficial ownership of less than 1% of the outstanding shares of our common stock. (1) This table is based upon information supplied by executive officers, directors and principal stockholders and in their filings with the SEC. Beneficial ownership is determined in accordance with the rules of the SEC and includes voting or investment power with respect to the securities. We deem shares of common stock that may be acquired by an individual or group within 60 days of March 1, 2024 pursuant to the exercise of options or warra